• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理性近视:我们目前的研究进展如何?

Pathologic myopia: where are we now?

作者信息

Tano Yasuo

机构信息

Department of Ophthalmology, Osaka University, Medical School, Osaka, Japan.

出版信息

Am J Ophthalmol. 2002 Nov;134(5):645-60. doi: 10.1016/s0002-9394(02)01883-4.

DOI:10.1016/s0002-9394(02)01883-4
PMID:12429239
Abstract

PURPOSE

To describe current concepts and available treatments for pathologic myopia.

DESIGN

Review of experimental and clinical studies.

METHODS

The demography, natural history, medical and surgical treatments for choroidal neovascular membrane, vitreoretinal interface disorders and future strategies for pathologic myopia are reviewed.

RESULTS

Several medical and surgical modalities are currently available to treat various complications of pathologic myopia. Macular translocation appears to stabilize or improve visual function in many eyes with choroidal neovascularization.

CONCLUSION

Newer strategies are emerging to better ameliorate or prevent the complications of pathologic myopia.

摘要

目的

描述病理性近视的当前概念及可用治疗方法。

设计

对实验性和临床研究的综述。

方法

回顾病理性近视的人口统计学、自然病史、脉络膜新生血管膜的医学和手术治疗、玻璃体视网膜界面疾病以及未来策略。

结果

目前有多种医学和手术方式可用于治疗病理性近视的各种并发症。黄斑转位术似乎能使许多患有脉络膜新生血管的眼睛的视功能稳定或改善。

结论

正在出现新的策略以更好地改善或预防病理性近视的并发症。

相似文献

1
Pathologic myopia: where are we now?病理性近视:我们目前的研究进展如何?
Am J Ophthalmol. 2002 Nov;134(5):645-60. doi: 10.1016/s0002-9394(02)01883-4.
2
Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization: a clinicopathologic case report.
Retina. 2002 Dec;22(6):818-24. doi: 10.1097/00006982-200212000-00027.
3
Lacquer cracks following laser treatment of choroidal neovascularization in pathologic myopia.
Retina. 1998;18(2):118-24. doi: 10.1097/00006982-199818020-00004.
4
[Morphological features of myopic choroidal neovascularization: differences to neovascular age-related macular degeneration].[近视性脉络膜新生血管的形态学特征:与年龄相关性黄斑变性新生血管的差异]
Ophthalmologe. 2012 Aug;109(8):749-57. doi: 10.1007/s00347-011-2498-3.
5
Recent trends in the management of maculopathy secondary to pathological myopia.病理性近视性黄斑病变的治疗新进展。
Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):3-13. doi: 10.1007/s00417-011-1889-0. Epub 2011 Dec 13.
6
[Macular choroidal thickness assessment with SD-OCT in high myopia with or without choroidal neovascularization].[使用频域光学相干断层扫描评估伴有或不伴有脉络膜新生血管的高度近视患者的黄斑脉络膜厚度]
J Fr Ophtalmol. 2013 Oct;36(8):687-92. doi: 10.1016/j.jfo.2013.03.009. Epub 2013 Jul 26.
7
Natural history of choroidal neovascularization in degenerative myopia.
Ophthalmology. 1984 Dec;91(12):1573-81. doi: 10.1016/s0161-6420(84)34116-1.
8
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.病理性近视性黄斑下脉络膜新生血管的维替泊芬治疗:一项随机临床试验的2年结果——VIP报告第3号
Ophthalmology. 2003 Apr;110(4):667-73. doi: 10.1016/s0161-6420(02)01998-x.
9
Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia.斑驳状萎缩和漆裂纹易导致病理性近视中脉络膜新生血管的形成。
Br J Ophthalmol. 2003 May;87(5):570-3. doi: 10.1136/bjo.87.5.570.
10
[Spectral domain optical coherence tomography in the treatment of myopic choroidal neovascularization].
Ophthalmologe. 2012 Aug;109(8):758-65. doi: 10.1007/s00347-011-2499-2.

引用本文的文献

1
Retardation of myopia by atropine regimes.阿托品疗法延缓近视进展
Int J Ophthalmol. 2024 Nov 18;17(11):2129-2140. doi: 10.18240/ijo.2024.11.20. eCollection 2024.
2
Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials.阿托品对儿童近视控制的疗效:一项随机对照试验的荟萃分析。
J Family Med Prim Care. 2022 Nov;11(11):6668-6677. doi: 10.4103/jfmpc.jfmpc_1339_22. Epub 2022 Dec 16.
3
Clinically Significant Axial Shortening in Myopic Children After Repeated Low-Level Red Light Therapy: A Retrospective Multicenter Analysis.
反复低强度红光治疗后近视儿童的临床显著轴向缩短:一项回顾性多中心分析
Ophthalmol Ther. 2023 Apr;12(2):999-1011. doi: 10.1007/s40123-022-00644-2. Epub 2023 Jan 7.
4
Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis.0.01%阿托品对近视儿童是一种有效且安全的治疗方法吗?一项系统评价与Meta分析
J Clin Med. 2021 Aug 24;10(17):3766. doi: 10.3390/jcm10173766.
5
Various cross-linking methods inhibit the collagenase I degradation of rabbit scleral tissue.各种交联方法抑制兔巩膜组织中胶原酶 I 的降解。
BMC Ophthalmol. 2020 Dec 14;20(1):488. doi: 10.1186/s12886-020-01751-z.
6
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients.阿柏西普治疗近视性脉络膜新生血管患者的初步研究。
BMC Ophthalmol. 2020 Oct 19;20(1):414. doi: 10.1186/s12886-020-01679-4.
7
Multimodal affine registration for ICGA and MCSL fundus images of high myopia.高度近视的吲哚青绿血管造影(ICGA)和微视野检查(MCSL)眼底图像的多模态仿射配准
Biomed Opt Express. 2020 Jul 20;11(8):4443-4457. doi: 10.1364/BOE.393178. eCollection 2020 Aug 1.
8
Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.1%阿托品滴眼液控制中国学龄儿童中高度近视进展的疗效和安全性。
Int J Med Sci. 2020 Jan 1;17(2):176-181. doi: 10.7150/ijms.39365. eCollection 2020.
9
Pattern and Presentation of Vitreo-Retinal Diseases: An Analysis of Retrospective Data at a Tertiary Eye Care Center in Nepal.玻璃体视网膜疾病的模式和表现:尼泊尔一家三级眼科保健中心的回顾性数据分析。
Asia Pac J Ophthalmol (Phila). 2019 Nov-Dec;8(6):481-488. doi: 10.1097/01.APO.0000604400.50700.2d.
10
Inverted ILM Flap for the Treatment of Myopic Macular Holes: Healing Processes and Morphological Changes in Comparison with Complete ILM Removal.倒置内界膜瓣治疗近视性黄斑裂孔:与完全切除内界膜相比的愈合过程及形态学变化
J Ophthalmol. 2019 Jun 2;2019:1314989. doi: 10.1155/2019/1314989. eCollection 2019.